Literature DB >> 11072184

Dosimetric comparison of pre-planned and or-planned prostate seed brachytherapy.

D A Wilkinson1, E J Lee, J P Ciezki, D S Mohan, C Zippe, K Angermeier, J Ulchaker, E A Klein, D Mohan.   

Abstract

PURPOSE: To compare the dosimetry of the traditional two step procedure (volume study + treatment planning several weeks later) with that of an OR-based single procedure in which these two steps follow one another immediately. Computer generated treatment plans were used in both procedures. METHODS AND MATERIALS: Several dosimetric parameters relating to target coverage were obtained from dose volume histograms of CT-based evaluation plans developed either 1 or 3 days following seed implantation. A total of 113 patients with early stage (T1C, T2A) prostate cancer were used for this retrospective study.
RESULTS: The fraction of target (prostate) covered by the prescription dose (144 Gy), 90% of the prescription dose (115 Gy), and the dose encompassing 90% of the target in the evaluation plan were all statistically significantly improved for OR-based plans compared to pre-planned cases.
CONCLUSION: In our hands, there is a small but significant improvement in dose coverage of the prostate when the ultrasound volume study and treatment planning are combined into a single procedure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072184     DOI: 10.1016/s0360-3016(00)00734-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Prostate brachytherapy for localized prostate cancer.

Authors:  Jay P Ciezki
Journal:  Curr Treat Options Oncol       Date:  2005-09

2.  On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.

Authors:  Z Jay Chen; Jun Deng; Kenneth Roberts; Ravinder Nath
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-05       Impact factor: 7.038

Review 3.  Brachytherapy with permanent seed implantation.

Authors:  Shiro Saito; Hirohiko Nagata; Michio Kosugi; Kazuhito Toya; Atsunori Yorozu
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

4.  Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience.

Authors:  Kana Kobayashi; Koji Okihara; Tsuyoshi Iwata; Norihiro Aibe; Naohiro Kodani; Takuji Tsubokura; Kazumi Kamoi; Tsuneharu Miki; Hideya Yamazaki
Journal:  J Radiat Res       Date:  2013-01-04       Impact factor: 2.724

Review 5.  Three-dimensional conformal brachytherapy for prostate cancer.

Authors:  Michael J Zelefsky
Journal:  Curr Urol Rep       Date:  2004-06       Impact factor: 2.862

6.  Influence of zonal dosimetry on prostate brachytherapy outcomes.

Authors:  Cheng William Hong; Chandana A Reddy; D Allan Wilkinson; Eric A Klein; Jay P Ciezki
Journal:  J Contemp Brachytherapy       Date:  2015-02-04

7.  Comparison of three different techniques of low-dose-rate seed implantation for prostate cancer.

Authors:  Hiromichi Ishiyama; Takefumi Satoh; Akane Sekiguchi; Ken-Ichi Tabata; Shouko Komori; Hideyasu Tsumura; Shogo Kawakami; Itaru Soda; Kouji Takenaka; Masatsugu Iwamura; Kazushige Hayakawa
Journal:  J Contemp Brachytherapy       Date:  2015-01-26

8.  Assessment of I-125 seed implant accuracy when using the live-planning technique for low dose rate prostate brachytherapy.

Authors:  Joshua Moorrees; John M Lawson; Loredana G Marcu
Journal:  Radiat Oncol       Date:  2012-11-22       Impact factor: 3.481

9.  Progressive transition from pre-planned to intraoperative optimizing seed implant: post implementation analysis.

Authors:  Hsiang-Chi Kuo; William Bodner; Ravindra Yaparpalvi; Chandan Guha; Bhupendra M Tolia; Keyur J Mehta; Dennis Mah; Shalom Kalnicki
Journal:  J Contemp Brachytherapy       Date:  2012-03-30

10.  Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer.

Authors:  Grant K Hunter; Chandana A Reddy; Eric A Klein; Patrick Kupelian; Kenneth Angermeier; James Ulchaker; Nabil Chehade; Andrew Altman; Jay P Ciezki
Journal:  Prostate Cancer       Date:  2012-04-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.